EMPAGLIFLOZIN Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A C-glycosyl compound consisting of a beta-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (Chemical Entities of Biological Interest Ontology, CHEBI_82720)
External Link https://dgidb.org/results?searchType=drug&searchTerms=EMPAGLIFLOZIN
Similar Terms
Downloads & Tools

Genes

5 interacting proteins for the EMPAGLIFLOZIN drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
ATP2A2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 3.5288
SLC5A2 solute carrier family 5 (sodium/glucose cotransporter), member 2 1.3233
SLC5A4 solute carrier family 5 (glucose activated ion channel), member 4 0.8822
SLC5A1 solute carrier family 5 (sodium/glucose cotransporter), member 1 0.622729
BDNF brain-derived neurotrophic factor 0.199743